With FDA nod, ChemoCentryx pill stands out in a sea of injectable & infused meds


ChemoCentryx has spent decades developing oral alternatives to injectable and infused biologic drugs that treat chronic autoimmune conditions. The research finally paid off with FDA approval of Tavneos, a ChemoCentryx pill for a rare autoimmune disease.

Leave a Reply